Prolonged Activated Partial Thromboplastin Time after Successful Resuscitation from Cardiac Arrest is Associated with Unfavorable Neurologic Outcome.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
Apr 2021
Historique:
pubmed: 14 11 2020
medline: 16 11 2021
entrez: 13 11 2020
Statut: ppublish

Résumé

Coagulation abnormalities after successful resuscitation from cardiac arrest may be associated with unfavorable neurologic outcome. We investigated a potential association of activated partial thromboplastin time (aPTT) with neurologic outcome in adult cardiac arrest survivors. Therefore, we included all adults ≥18 years of age who suffered a nontraumatic cardiac arrest and had achieved return of spontaneous circulation between January 2013 and December 2018. Patients receiving anticoagulants or thrombolytic therapy and those subjected to extracorporeal membrane oxygenation support were excluded. Routine blood sampling was performed on admission as soon as a vascular access was available. The primary outcome was 30-day neurologic function, assessed by the Cerebral Performance Category scale (3-5 = unfavorable neurologic function). Multivariable regression was used to assess associations between normal (≤41 seconds) and prolonged (>41 seconds) aPTT on admission (exposure) and the primary outcome. Results are given as odds ratio (OR) with 95% confidence intervals (95% CIs). Out of 1,591 cardiac arrest patients treated between 2013 and 2018, 360 patients (32% female; median age: 60 years [interquartile range: 48-70]) were eligible for analysis. A total of 263 patients (73%) had unfavorable neurologic function at day 30. aPTT prolongation >41 seconds was associated with a 190% increase in crude OR of unfavorable neurologic function (crude OR: 2.89; 95% CI: 1.78-4.68,

Identifiants

pubmed: 33186992
doi: 10.1055/s-0040-1719029
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-483

Subventions

Organisme : SFB54-04
ID : Austrian Science Fund FWF

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Christoph Schriefl (C)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Christian Schoergenhofer (C)

Department of Clinical Pharmacology, Medical University of Vienna, Austria.

Juergen Grafeneder (J)

Department of Clinical Pharmacology, Medical University of Vienna, Austria.

Michael Poppe (M)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Christian Clodi (C)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Matthias Mueller (M)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Florian Ettl (F)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Bernd Jilma (B)

Department of Clinical Pharmacology, Medical University of Vienna, Austria.

Pia Wallmueller (P)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Nina Buchtele (N)

Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Constantin Weikert (C)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Heidrun Losert (H)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Michael Holzer (M)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Fritz Sterz (F)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Michael Schwameis (M)

Department of Emergency Medicine, Medical University of Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH